Latest News
ProBio and Kun Tuo collaborate to deliver integrated CDMO-CRO solutions for advanced therapies
17 September 2026 - ProBio Inc, a global contract development and manufacturing organisation (CDMO) involved in biologics and cell and gene therapies (CGT), announced on Wednesday a strategic collaboration with clinical research organisation (CRO) Ku...
Myosin Therapeutics chosen for 2026-2027 NCI Investor Initiatives Showcase
17 September 2026 - Myosin Therapeutics Inc, a clinical-stage biotechnology company developing a new class of therapies targeting cancer cell mechanics, announced on Thursday its selection as a 2026–2027 National Cancer Institute (NCI) Investor...
Sobi and Innate confirm strategic partnership
17 September 2026 - Biopharmaceutical company Swedish Orphan Biovitrum AB (Sobi) (STO:SOBI) and clinical-stage biotechnology company Innate Pharma SA (Euronext Paris:IPH) (Nasdaq:IPHA) confirmed on Wednesday that their previously announced strategic ...
Viatris receives Japanese approval for WAKIX in narcolepsy and sleep apnoea
16 September 2026 - Healthcare company Viatris Inc (Nasdaq: VTRS) announced on Wednesday that it has received approval from Japan's Ministry of Health, Labour and Welfare for WAKIX (pitolisant) to treat excessive daytime sleepiness associated wi...
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery syst...